Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-08-14

FDA Approved: ORPHENADRINE CITRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental application for Orphenadrine citrate, enabling a new generic version of the muscle relaxant to be marketed. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Orphenadrine citrate (Orphenadrine citrate)

Snippet

SUPPL AP for ORPHENADRINE CITRATE (ORPHENADRINE CITRATE)